Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2017, Vol. 8 Issue (6) : 850-867     DOI: 10.14336/AD.2017.0829
Review |
The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review
Wei Liang,Xiaobo Huang,Wenqiang Chen
Department of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
Download: PDF(1036 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

Ischemic stroke, producing a high mortality and morbidity rate, is a common clinical disease. Enhancing the prevention and control of ischemic stroke is particularly important. Baicalin and its aglycon baicalein are flavonoids extracted from Scutellaria baicalensis, an important traditional Chinese herb. In recent years, a growing body of evidences has shown that baicalin and baicalein could be effective in the treatment of cerebral ischemia. Pharmacokinetic studies have shown that baicalin could penetrate the blood-brain barrier and distribute in cerebral nuclei. Through a variety of in vitro and in vivo models of ischemic neuronal injury, numerous studies have demonstrated that baicalin and baicalein have salutary effect for neuroprotection. Especially, the studies on the pharmacological mechanism showed that baicalin and baicalein have several pharmacological activities, which include antioxidant, anti-apoptotic, anti-inflammatory and anti-excitotoxicity effects, protection of the mitochondria, promoting neuronal protective factors expression and adult neurogenesis effects and many more. This review focuses on the neuroprotective effects of baicalin and baicalein in ischemia or stroke-induced neuronal cell death. We aimed at collecting all important information regarding the neuroprotective effect and its pharmacological mechanism of baicalin and baicalein in various in vivo and in vitro experimental models of ischemic neuronal injury.

Keywords baicalin      baicalein      cerebral ischemia      neuronal protection     
Corresponding Authors: Wenqiang Chen   
Issue Date: 01 December 2017
E-mail this article
E-mail Alert
Articles by authors
Wei Liang
Xiaobo Huang
Wenqiang Chen
Cite this article:   
Wei Liang,Xiaobo Huang,Wenqiang Chen. The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review[J]. A&D, 2017, 8(6): 850-867.
URL:     OR
[1] Willis JC, editors. A dictionary of the flowering plants and ferns. 7th edition. UK: Cambridge University Press; 1966
[2] Bruno M, Piozzi F, Maggio AM, Simmonds MSJ (2002). Antifeedant activity of neoclerodane diterpenoids from two Sicilian species of Scutellaria. Biochem Syst Ecol, 30: 793-799
[3] Gaire BP, Moon SK, Kim H (2014). Scutellaria baicalensis in stroke management: nature's blessing in traditional Eastern medicine. Chin J Integr Med, 20: 712-720
[4] Shang X, He X, He X, Li M, Zhang R, Fan P, et al. (2010). The genus Scutellaria an ethnopharmacological and phytochemical review. J Ethnopharmacol, 128: 279-313
[5] Orhan IE, Daglia M, Nabavi SF, Loizzo MR, Sobarzo-Sánchez E, Nabavi SM (2015). Flavonoids and dementia: an update. Curr Med Chem, 22: 1004-1015
[6] de Oliveira MR, Nabavi SF, Habtemariam S, Erdogan Orhan I, Daglia M, Nabavi SM (2015). The effects of baicalein and baicalin on mitochondrial function and dynamics: A review. Pharmacol Res, 100: 296-308
[7] Li BQ, Fu T, Yan YD, Baylor NW, Ruscetti FW, Kung HF (1993). Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res, 39: 119-124
[8] Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Hsu JD, et al. (2005). Protective effect of baicalin on tert-butyl hydroperoxide-induced rat hepatotoxicity. Arch Toxicol, 79: 102-109
[9] Li-Weber M (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev, 35: 57-68
[10] Kimura Y, Yokoi K, Matsushita N, Okuda H (1997). Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. J Pharm Pharmacol, 49: 816-822
[11] Zhang ZJ, Wang Z, Zhang XY, Ying K, Liu JX, Wang YY (2005). Gene expression profile induced by oral administration of baicalin and gardenin after focal brain ischemia in rats. Acta Pharmacol Sin, 26: 307-314
[12] Hong KS, Saver JL (2009). Quantifying the Value of Stroke Disability Outcomes: WHO Global Burden of Disease Project Disability Weights for Each Level of the Modified Rankin Scale. Stroke, 40: 3828-3833
[13] Goldstein LB, Rothwell PM (2008). Advances in prevention and health services delivery 2007. Stroke, 39: 258-260
[14] Chan PH (2004). Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res, 29: 1943-1949
[15] Yang Y, Rosenberg GA (2011). Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke, 42: 3323-3328
[16] Li C, Lin G, Zuo Z (2011). Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos, 32: 427-445
[17] Zhang L, Lin G, Kovács B, Jani M, Krajcsi P, Zuo Z (2007). Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci, 31: 221-231
[18] Akao T, Sakashita Y, Hanada M, Goto H, Shimada Y, Terasawa K (2004). Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2. Pharm Res, 21: 2120-2126
[19] Taiming L, Xuehua J (2006). Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharm Sci, 95: 1326-1333
[20] Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, et al. (2000). Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol, 52: 1563-1568
[21] Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G (2003). Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol, 65: 1199-1206
[22] Xing J, Chen X, Zhong D (2005). Absorption and enterohepatic circulation of baicalin in rats. Life Sci, 78: 140-146
[23] Tang Y, Zhu H, Zhang Y, Huang C (2006). Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography. Biomed Chromatogr, 20: 1116-1119
[24] Huang H, Zhang Y, Yang R, Tang X (2008). Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 874: 77-83
[25] Zhang L, Xing D, Wang W, Wang R, Du L (2006). Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract. J Ethnopharmacol, 103: 120-125
[26] Lai MY, Hsiu SL, Chen CC, Hou YC, Chao PD (2003). Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans. Biol Pharm Bull, 26: 79-83
[27] Zhang L, Lin G, Chang Q, Zuo Z (2005). Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm Res, 22: 1050-1058
[28] Akao T, Sato K, Hanada M (2009). Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat. Biol Pharm Bull, 32: 2079-2082
[29] Liu L, Deng YX, Liang Y, Pang XY, Liu XD, Liu YW, et al. (2010). Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase. Planta Med, 76: 70-75
[30] Walle T (2004). Absorption and metabolism of flavonoids. Free Radic Biol Med, 36: 829-837
[31] Ma SW, Zhao M, Liu HX, Wang LY, Zhang XT (2012). Pharmacokinetic Effects of Baicalin on Cerebral Ischemia-reperfusion after iv Administration in Rats. Chin Herb Med, 4: 53-57
[32] Zeng MF, Pan LM, Zhu HX, Zhang QC, Guo LW (2010). Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats. Fitoterapia, 81: 490-496
[33] Liu Z, Zhang L, He Q, Liu X, Okeke CI, Tong L, et al. (2015). Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats. Int J Pharm, 489: 131-138
[34] Fan L, Wang JC, Jiang F, Tan ZR, Chen Y, Li Q, et al. (2009). Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation. Eur J Clin Pharmacol, 65: 403-409
[35] Jang SI, Kim HJ, Hwang KM, Jekal SJ, Pae HO, Choi BM, et al. (2003). Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol, 25: 585-594
[36] Xing J, Chen X, Sun Y, Luan Y, Zhong D (2005). Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharm Pharmacol, 57: 743-750
[37] Srinivas NR (2010). Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica, 40: 357-367
[38] Lapchak PA, Maher P, Schubert D, Zivin JA (2007). Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience, 150: 585-591
[39] Liu C, Wu J, Xu K, et al. (2010). Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J Neurochem, 112: 1500-1512
[40] Li HY, Hu J, Zhao S, Yuan ZY, Wan HJ, Lei F, et al. (2012). Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2/TNFα. J Biomed Biotechnol, 2012: 267890
[41] Wang P, Cao Y, Yu J, Liu R, Bai B, Qi H, et al. (2016). Baicalin alleviates ischemia-induced memory impairment by inhibiting the phosphorylation of CaMKII in hippocampus. Brain Res, 1642: 95-103
[42] He XL, Wang YH, Gao M, Li XX, Zhang TT, Du GH (2009). Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Res, 1249: 212-221
[43] Cui L, Zhang X, Yang R, Liu L, Wang L, Li M, et al. (2010). Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. Pharmacol Biochem Behav, 96: 469-475
[44] Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH, Chen CM, et al. (2011). Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation, 34: 463-470
[45] Xue X, Qu XJ, Yang Y, Sheng XH, Cheng F, Jiang EN, et al. (2010). Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochem Biophys Res Commun, 403: 398-404
[46] Cao Y, Mao X, Sun C, Zheng P, Gao J, Wang X, et al. (2011). Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull, 85: 396-402
[47] Cheng O, Li Z, Han Y, Jiang Q, Yan Y, Cheng K (2012). Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis. Brain Res, 1470: 111-118
[48] Cheng F, Lu Y, Zhong X, Song W, Wang X, Sun X, et al. (2013). Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo. Evid Based Complement Alternat Med, 2013: 120261
[49] Liu C, Wu J, Gu J, Xiong Z, Wang F, Wang J, et al. (2007). Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav, 86: 423-430
[50] Yamada J, Yoshimura S, Yamakawa H, Sawada M, Nakagawa M, Hara S, et al. (2003). Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci Res, 45: 1-8
[51] Manning BD, Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell, 129: 1261-1274
[52] Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, et al. (2008). Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin, 29: 74-82
[53] Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378: 785-789
[54] Hong KW, Lee JH, Kima KY, Park SY, Lee WS (2006). Cilostazol: therapeutic potential against focal cerebral ischemic damage. Curr Pharm Des, 12: 565-573
[55] Szabo C, Ischiropoulos H, Radi R (2007). Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov, 6: 662-680
[56] Thiyagarajan M, Kaul CL, Sharma SS (2004). Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br J Pharmacol, 142: 899-911
[57] Xu M, Chen X, Gu Y, Peng T, Yang D, Chang RC, et al. (2013). Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury. J Ethnopharmacol, 150: 116-124
[58] Yuan J, Murrell GA, Trickett A, Wang MX (2003). Involvement of cytochrome c release and caspase-3 activation in the oxidative stress-induced apoptosis in human tendon fibroblasts. Biochim Biophys Acta, 1641: 35-41
[59] Sehara Y, Sawicka K, Hwang JY, Latuszek-Barrantes A, Etgen AM, Zukin RS (2013). Survivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia. J Neurosci, 33: 12364-12374
[60] Zheng WX, Wang F, Cao XL, Pan HY, Liu XY, Hu XM, et al. (2014). Baicalin protects PC-12 cells from oxidative stress induced by hydrogen peroxide via anti-apoptotic effects. Brain Inj, 28: 227-234
[61] Wang W, Xu J, Li L, Wang P, Ji X, Ai H, et al. (2010). Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull, 83: 196-201
[62] Knöll B, Nordheim A (2009). Functional versatility of transcription factors in the nervous system: the SRF paradigm. Trends Neurosci, 32: 432-442
[63] Zheng WX, Cao XL, Wang F, Wang J, Ying TZ, Xiao W, et al. (2015). Baicalin inhibiting cerebral ischemia/hypoxia-induced neuronal apoptosis via MRTF-A-mediated transactivity. Eur J Pharmacol, 767: 201-210
[64] Yang DD, Kuan CY, Whitmarsh AJ, Rincön M, Zheng TS, Davis RJ, et al. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature, 389: 865-870
[65] Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270: 1326-1331
[66] Dai J, Chen L, Qiu YM, Li SQ, Xiong WH, Yin YH, et al. (2013). Activations of GABAergic signaling, HSP70 and MAPK cascades are involved in baicalin's neuroprotection against gerbil global ischemia/reperfusion injury. Brain Res Bull, 90: 1-9
[67] Famakin BM (2014). The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review. Aging Dis, 5: 307-326
[68] Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al. (2007). Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A, 104: 13798-13803
[69] Doll DN, Barr TL, Simpkins JW (2014). Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis, 5: 294-306
[70] Vartanian K, Stenzel-Poore M (2010). Toll-like receptor tolerance as a mechanism for neuroprotection. Transl Stroke Res, 1: 252-260
[71] Farias SE, Basselin M, Chang L, Heidenreich KA, Rapoport SI, Murphy RC (2008). Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res, 49: 1990-2000
[72] Inohara N, Nuñez G (2003). NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol, 3: 371-382
[73] Li H, Hu J, Ma L, Yuan Z, Wang Y, Wang X, et al. (2010). Comprehensive study of baicalin down-regulating NOD2 receptor expression of neurons with oxygen-glucose deprivation in vitro and cerebral ischemia-reperfusion in vivo. Eur J Pharmacol, 649: 92-99
[74] Zhao Y, Patzer A, Gohlke P, Herdegen T, Culman J (2005). The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci, 22: 278-282
[75] Xu YW, Sun L, Liang H, Sun GM, Cheng Y (2010). 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res, 1307: 149-157
[76] Li H, Siegel RE, Schwartz RD (1993). Rapid decline of GABAA receptor subunit mRNA expression in hippocampus following transient cerebral ischemia in the gerbil. Hippocampus, 3: 527-537
[77] Kang TC, An SJ, Park SK, Hwang IK, Yoon DK, Shin HS, et al. (2002). Changes in Na(+)-K(+)-Cl(-) cotransporter immunoreactivity in the gerbil hippocampus following transient ischemia. Neurosci Res, 44: 249-254
[78] Shen Y, He P, Fan YY, Zhang JX, Yan HJ, Hu WW, et al. (2010). Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic Biol Med, 48: 727-735
[79] Zhong X, Li X, Qian L, Xu Y, Lu Y, Zhang J, et al. (2012). Glycine attenuates myocardial ischemia-reperfusion injury by inhibiting myocardial apoptosis in rats. J Biomed Res, 26: 346-354
[80] Hajimohammadreza I, Probert AW, Coughenour LL, Borosky SA, Marcoux FW, Boxer PA, et al. (1995). A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J Neurosci, 15: 4093-4101
[81] Lu M, Tang F, Zhang J, Luan A, Mei M, Xu C, et al. (2015). Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway. Phytother Res, 29: 599-606
[82] Zhou QB, Ju XN, Wang XY, Wang MH, Kong F, Sun C, et al. (2016). Pretreatment with baicalin attenuates hypoxia and glucose deprivation-induced injury in SH-SY5Y cells. Chin J Integr Med, 22: 201-206
[83] Li XX, He GR, Mu X, Xu B, Tian S, Yu X, et al. (2012). Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. Eur J Pharmacol, 674: 227-233
[84] Hawkins BT, Davis TP (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev, 57: 173-185
[85] Tavelin S, Hashimoto K, Malkinson J, Lazorova L, Toth I, Artursson P (2003). A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol, 64: 1530-1540
[86] Ren C, Li N, Wang B, Yang Y, Gao J, Li S, et al. (2015). Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia. Aging Dis, 6: 406-417
[87] Tu XK, Yang WZ, Liang RS, Shi SS, Chen JP, Chen CM, et al. (2011). Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res, 36: 2022-2028
[88] Van Itallie CM, Anderson JM (2004). The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc, 1: 38-41
[89] Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S (2006). Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun, 339: 1197-1203
[90] Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV (2006). Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem, 281: 8379-8388
[91] Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W (2004). Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol, 198: 359-369
[92] Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, et al. (2012). Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol, 141: 714-720
[93] Luo W, Wang Y, Reiser G (2007). Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev, 56: 331-345
[94] Li H, Wu H, Huang X (2009). The expression and significance of thrombin and PAR-1 following focal cerebral ischemia reperfusion in rats. Stroke Nerv Dis, 16: 20-25
[95] Zhou QB, Duan CZ, Jia Q, Liu P, Li LY (2014). Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis. Chin J Integr Med, 20: 116-122
[96] Tsuchiya D, Hong S, Matsumori Y, Kayama T, Swanson RA, Dillman WH, et al. (2003). Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery, 53: 1179-1187
[97] Ferrer I, Ballabriga J, Marti E, Pérez E, Alberch J, Arenas E (1998). BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol, 8: 253-261
[98] Conover JC, Shook BA (2011). Aging of the subventricular zone neural stem cell niche. Aging Dis, 2: 49-63
[99] Taupin P, Gage FH (2002). Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res, 69: 745-749
[100] Burdon T, Smith A, Savatier P (2002). Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol, 12: 432-438
[101] Ohtsuka T, Sakamoto M, Guillemot F, Kageyama R (2001). Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain. J Biol Chem, 276: 30467-30474
[102] Lo L, Tiveron MC, Anderson DJ (1998). MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development, 125: 609-620
[103] Li Y, Zhuang P, Shen B, Zhang Y, Shen J (2012). Baicalin promotes neuronal differentiation of neural stem/progenitor cells through modulating p-stat3 and bHLH family protein expression. Brain Research, 1429: 36-42
[104] Jaken S (2003). An overlay assay for detecting protein kinase C-binding proteins and substrates. Methods Mol Biol, 233: 359-368
[105] Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, et al. (2000). The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem, 75: 91-100
[106] Zhang Z, Wu R, Li P, Liu F, Zhang W, Zhang P, et al. (2009). Baicalin administration is effective in positive regulation of twenty-four ischemia/reperfusion-related proteins identified by a proteomic study. Neurochem Int, 54: 488-496
[107] Li H, Zhang Y, Yu Y, Li B, Chen Y, Wu H, et al. (2013). Systemic revealing pharmacological signalling pathway networks in the hippocampus of ischaemia-reperfusion mice treated with baicalin. Evid Based Complement Alternat Med, 2013: 630723
[108] Gao Z, Huang K, Xu H (2001). Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res, 43: 173-178
[109] Lee HH, Yang LL, Wang CC, Hu SY, Chang SF, Lee YH (2003). Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res, 986: 103-113
[1] Yuanyuan Ran,Zongjian Liu,Shuo Huang,Jiamei Shen,Fengwu Li,Wenxiu Zhang,Chen Chen,Xiaokun Geng,Zhili Ji,Huishan Du,Xiaoming Hu. Splenectomy Fails to Provide Long-Term Protection Against Ischemic Stroke[J]. A&D, 2018, 9(3): 467-479.
[2] Chengjie Zhang,Yanbing Zhu,Song Wang,Zheng Zachory Wei,Michael Qize Jiang,Yongbo Zhang,Yuhualei Pan,Shaoxin Tao,Jimei Li,Ling Wei. Temporal Gene Expression Profiles after Focal Cerebral Ischemia in Mice[J]. A&D, 2018, 9(2): 249-261.
[3] Jue Wang,Bin Cao,Dong Han,Miao Sun,Juan Feng. Long Non-coding RNA H19 Induces Cerebral Ischemia Reperfusion Injury via Activation of Autophagy[J]. A&D, 2017, 8(1): 71-84.
[4] Yaohui Tang,Liuqing Wang,Jixian Wang,Xiaojie Lin,Yongting Wang,Kunlin Jin,Guo-Yuan Yang. Ischemia-induced Angiogenesis is Attenuated in Aged Rats[J]. A&D, 2016, 7(4): 326-335.
[5] Bolanle M. Famakin. The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review[J]. Aging and Disease, 2014, 5(5): 307-326.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd